MichaelA.MorganMD

PubMed

• The ethical and technical aspects of urinary diversions in low-resource settings: a commentary.
  Wilkinson, J.,Pope, R.,Kammann, T. J.,Scarpato, K.,Raassen, T.,Bishop, M. C.,Morgan, M.,Cartmell, M. T.,Chipungu, E.,Sion, M.,Weinstein, M.,Lengmang, S. J.,Mabeya, H.,...> ;BJOG. 2016 Mar 01
• Paraxial and nonparaxial polynomial beams and the analytic approach to propagation.
  Dennis, M. R., Götte, J. B., King, R. P., Morgan, M. A., Alonso, M. A.> ;Opt Lett. 2011 Nov 15
• Modulation of anthracycline-induced cytotoxicity by targeting the prenylated proteome in myeloid leukemia cells.
  Morgan, M.A., Onono, F.O., Spielmann, H.P., Subramanian, T., Scherr, M., Venturini, L., Dallmann, I., Ganser, A., Reuter, C.M.> ;J Mol Med (Berl). 2012 Feb
• A tagging-via-substrate approach to detect the farnesylated proteome using two-dimensional electrophoresis coupled with Western blotting.
  Onono, F.O., Morgan, M.A., Spielmann, H.P., Andres, D.A., Subramanian, T., Ganser, A., Reuter, C.M.> ;Mol Cell Proteomics. 2010 Apr
• Going from genes to proteins in myelodysplastic syndromes.
  Ganser, A., Morgan, M.A., Weissinger, E.M.> ;Proc Natl Acad Sci U S A. 2007 Jan 23
• Candida kefyr as an emerging pathogen causing nosocomial bloodstream infections in neutropenic leukemia patients.
  Reuter, C.M., Morgan, M.A., Bange, F., Gunzer, F., Eder, M., Hertenstein, B., Ganser, A.> ;Clin Infect Dis. 2005 Nov 1
• Single-molecule spectroscopic determination of lac repressor-DNA loop conformation.
  Morgan, M.A., Okamoto, K., Kahn, J.D., English, D.S.> ;Biophys J. 2005 Oct
• Prospective comparison of transthoracic versus transhiatal esophagectomy following neoadjuvant therapy for esophageal cancer.
  Morgan, M. A., Lewis, W. G., Hopper, A. N., Escofet, X., Havard, T. J., Brewster, A. E., Crosby, T. D., Roberts, S. A., Clark, G. W.> ;Dis Esophagus. 2007
• Treatment of advanced and recurrent endometrial cancer with cisplatin, doxorubicin, and cyclophosphamide.
  Dunton, C. J., Pfeifer, S. M., Braitman, L. E., Morgan, M. A., Carlson, J. A., Mikuta, J. J.> ;Gynecol Oncol. 1991 May
• Prognostic significance of body mass indices for patients undergoing esophagectomy for cancer.
  Morgan, M. A., Lewis, W. G., Hopper, A. N., Escofet, X., Harvard, T. J., Brewster, A. E., Crosby, T. D., Roberts, S. A., Clark, G. W.> ;Dis Esophagus. 2007
• Oxidant stress is increased during treatment of human immunodeficiency virus infection.
  Hulgan, T., Morrow, J., D'Aquila, R. T., Raffanti, S., Morgan, M., Rebeiro, P., Haas, D. W.> ;Clin Infect Dis. 2003 Dec 15
• Secondary cytoreduction in epithelial ovarian cancer.
  Morgan, M. A., Rubin, S. C.> ;Crit Rev Oncol Hematol. 1995 Jan
• Septic arthritis and bacteremia due to Mycoplasma resistant to antimicrobial therapy in a patient with systemic lupus erythematosus.
  Clough, W., Cassell, G. H., Duffy, L. B., Rinaldi, R. Z., Bluestone, R., Morgan, M. A., Meyer, R. D.> ;Clin Infect Dis. 1992 Sep
• Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinoma.
  Morgan, M. A., Lewis, W. G., Casbard, A., Roberts, S. A., Adams, R., Clark, G. W., Havard, T. J., Crosby, T. D.> ;Br J Surg. 2009 Nov 01
• Prognostic significance of failure to cross esophageal tumors by endoluminal ultrasound.
  Morgan, M. A., Twine, C. P., Lewis, W. G., Lambe, R., Oliphant, H. E., Robinson, M., Crosby, T. D., Roberts, S. A.> ;Dis Esophagus. 2008
• Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1.
  Rubin, S. C., Benjamin, I., Behbakht, K., Takahashi, H., Morgan, M. A., LiVolsi, V. A., Berchuck, A., Muto, M. G., Garber, J. E., Weber, B. L., Lynch, H. T., Boyd, J.> ;N Engl J Med. 1996 Nov 7
• Prospective cohort comparison of neoadjuvant chemoradiotherapy versus chemotherapy in patients with oesophageal cancer.
  Morgan, M. A., Lewis, W. G., Crosby, T. D., Escofet, X., Roberts, S. A., Brewster, A. E., Harvard, T. J., Clark, G. W.> ;Br J Surg. 2007 Dec
• Phase II multicenter open-label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.
  Kavanagh, J. J., Sill, M. W., Ramirez, P. T., Warshal, D., Pearl, M. L., Morgan, M. A.> ;Int J Gynecol Cancer. 2008 May 01
• Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
  Schlenk, R. F., Döhner, K., Krauter, J., Fröhling, S., Corbacioglu, A., Bullinger, L., Habdank, M., Späth, D., Morgan, M., Benner, A., Schlegelberger, B., Heil, G., Ga...> ;N Engl J Med. 2008 May 1
• Cycles of dose-intensive chemotherapy with peripheral stem cell support in persistent or recurrent platinum-sensitive ovarian cancer.
  Morgan, M. A., Stadtmauer, E. A., Luger, S. M., Porter, D. L., Mangan, P. A., O'Neil, P., Kamelle, S., Benjamin, I., Mick, R., King, S. A., Rubin, S. C.> ;Gynecol Oncol. 1997 Dec
• Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.
  Thol, F., Damm, F., Lüdeking, A., Winschel, C., Wagner, K., Morgan, M., Yun, H., Göhring, G., Schlegelberger, B., Hoelzer, D., Lübbert, M., Kanz, L., Fiedler, W., Kirc...> ;J Clin Oncol. 2011 Jul 20
• Phosphoinositide phospholipase Cbeta1 (PI-PLCbeta1) gene in myelodysplastic syndromes and cytogenetically normal acute myeloid leukemia: not a deletion, but increased ...
  Damm, F., Lange, K., Heuser, M., Oberacker, T., Morgan, M., Wagner, K., Krauter, J., Schlegelberger, B., Ganser, A., Göhring, G.> ;J Clin Oncol. 2010 Aug 1
• Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemia.
  Damm, F., Oberacker, T., Thol, F., Surdziel, E., Wagner, K., Chaturvedi, A., Morgan, M., Bomm, K., Göhring, G., Lübbert, M., Kanz, L., Fiedler, W., Schlegelberger, B.,...> ;J Clin Oncol. 2011 Feb 20
• Pre T-cell receptor alpha (pTalpha) expression patterns and functional analysis in human T-cell lymphoblastic leukemia.
  Ivanyi, P., Morgan, M., Piao, W., Ukena, S. N., Steube, K., Ganser, A., Franzke, A.> ;Cell Oncol. 2010
• Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia.
  Damm, F., Heuser, M., Morgan, M., Yun, H., Grosshennig, A., Göhring, G., Schlegelberger, B., Döhner, K., Ottmann, O., Lübbert, M., Heit, W., Kanz, L., Schlimok, G., Ra...> ;J Clin Oncol. 2010 Feb 1
• Join now to see all